Hepatitis C Treatment Snapshots: Daclatasvir

Hepatitis C Treatment Snapshots: Daclatasvir

For a simplified snapshot from TREAT Asia/amfAR on daclatasvir, a second generation direct-acting antiviral for the treatment of hepatitis C, please click here.

/ News

buy Lyrica in uk Share the Post

Bremervörde Related Posts

BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Know the interactions between HIV and Hep C medicines
Hepatitis C vaccine fails to prevent chronic infections
Progress report on access to hepatitis C treatment, WHO March 2018
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015